Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095637282> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2095637282 endingPage "32" @default.
- W2095637282 startingPage "4427" @default.
- W2095637282 abstract "Using multidrug-resistant (MDR)-transgenic mice, whose bone marrow cells express the human MDR1 gene at a level approximately equal to that found in many human cancers, we determined the efficacy of human-specific anti-P-glycoprotein monoclonal antibody MRK16 in overcoming multidrug resistance in an intact animal. MRK16 alone (2 mg) did not significantly affect the WBC counts of the MDR-transgenic mice, but MRK16, as well as the F(ab')2 fragments of MRK16, led to a dose-dependent circumvention of bone marrow resistance against daunomycin, doxorubicin, vincristine, vinblastine, etoposide, and taxol. This sensitizing effect could not be enhanced by combining MRK16 with low molecular weight chemosensitizing agents such as verapamil, quinine, quinidine, or cyclosporin A. We also investigated the concept of specifically targeting and killing multidrug-resistant cells by using MRK16 coupled to Pseudomonas exotoxin (PE). MRK16-PE resulted in a dose-dependent killing of bone marrow cells in MDR-transgenic mice, whereas no bone marrow toxicity was observed in normal control mice. Administration of excess MRK16 prior to injection of MRK16-PE successfully blocked the effect of MRK16-PE. MOPC-PE, a non-MDR-related control monoclonal antibody conjugate, did not target and kill multidrug-resistant bone marrow cells in MDR-transgenic mice. Thus, these immunological approaches to reversing multidrug resistance appear to be both specific and effective." @default.
- W2095637282 created "2016-06-24" @default.
- W2095637282 creator A5000785078 @default.
- W2095637282 creator A5006158324 @default.
- W2095637282 creator A5030334751 @default.
- W2095637282 creator A5056573254 @default.
- W2095637282 date "1992-08-15" @default.
- W2095637282 modified "2023-10-17" @default.
- W2095637282 title "Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice." @default.
- W2095637282 cites W1567907251 @default.
- W2095637282 cites W1598654033 @default.
- W2095637282 cites W1998650250 @default.
- W2095637282 cites W2004862394 @default.
- W2095637282 cites W2005877531 @default.
- W2095637282 cites W2018577228 @default.
- W2095637282 cites W2024463580 @default.
- W2095637282 cites W2025476834 @default.
- W2095637282 cites W2035544432 @default.
- W2095637282 cites W2075749214 @default.
- W2095637282 cites W2078877172 @default.
- W2095637282 cites W2084336061 @default.
- W2095637282 cites W2093180739 @default.
- W2095637282 cites W2097878215 @default.
- W2095637282 cites W2100837269 @default.
- W2095637282 cites W2107615796 @default.
- W2095637282 cites W2121167726 @default.
- W2095637282 cites W2122322546 @default.
- W2095637282 cites W2135416887 @default.
- W2095637282 cites W2138993111 @default.
- W2095637282 cites W2144302996 @default.
- W2095637282 cites W2156783211 @default.
- W2095637282 cites W2321867218 @default.
- W2095637282 cites W2415990034 @default.
- W2095637282 cites W2507629633 @default.
- W2095637282 cites W2615953705 @default.
- W2095637282 cites W35929032 @default.
- W2095637282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1353705" @default.
- W2095637282 hasPublicationYear "1992" @default.
- W2095637282 type Work @default.
- W2095637282 sameAs 2095637282 @default.
- W2095637282 citedByCount "15" @default.
- W2095637282 countsByYear W20956372822016 @default.
- W2095637282 countsByYear W20956372822018 @default.
- W2095637282 crossrefType "journal-article" @default.
- W2095637282 hasAuthorship W2095637282A5000785078 @default.
- W2095637282 hasAuthorship W2095637282A5006158324 @default.
- W2095637282 hasAuthorship W2095637282A5030334751 @default.
- W2095637282 hasAuthorship W2095637282A5056573254 @default.
- W2095637282 hasConcept C114851261 @default.
- W2095637282 hasConcept C133936738 @default.
- W2095637282 hasConcept C142724271 @default.
- W2095637282 hasConcept C203014093 @default.
- W2095637282 hasConcept C2780007613 @default.
- W2095637282 hasConcept C71924100 @default.
- W2095637282 hasConcept C86803240 @default.
- W2095637282 hasConcept C89423630 @default.
- W2095637282 hasConceptScore W2095637282C114851261 @default.
- W2095637282 hasConceptScore W2095637282C133936738 @default.
- W2095637282 hasConceptScore W2095637282C142724271 @default.
- W2095637282 hasConceptScore W2095637282C203014093 @default.
- W2095637282 hasConceptScore W2095637282C2780007613 @default.
- W2095637282 hasConceptScore W2095637282C71924100 @default.
- W2095637282 hasConceptScore W2095637282C86803240 @default.
- W2095637282 hasConceptScore W2095637282C89423630 @default.
- W2095637282 hasIssue "16" @default.
- W2095637282 hasLocation W20956372821 @default.
- W2095637282 hasOpenAccess W2095637282 @default.
- W2095637282 hasPrimaryLocation W20956372821 @default.
- W2095637282 hasRelatedWork W1970707390 @default.
- W2095637282 hasRelatedWork W1971419911 @default.
- W2095637282 hasRelatedWork W2027717767 @default.
- W2095637282 hasRelatedWork W2067699521 @default.
- W2095637282 hasRelatedWork W2152835711 @default.
- W2095637282 hasRelatedWork W2321288317 @default.
- W2095637282 hasRelatedWork W2338658757 @default.
- W2095637282 hasRelatedWork W2371279320 @default.
- W2095637282 hasRelatedWork W3032513420 @default.
- W2095637282 hasRelatedWork W74504067 @default.
- W2095637282 hasVolume "52" @default.
- W2095637282 isParatext "false" @default.
- W2095637282 isRetracted "false" @default.
- W2095637282 magId "2095637282" @default.
- W2095637282 workType "article" @default.